The THERAPEUTIC POTENTIAL: UNDARIA PINNATIFIDA AND MORINGA OLEIFERA EXTRACTS AS MODULATORS OF ADIPOGENESIS IN 3T3-L1 ADIPOCYTES

Authors

  • SAI KALYANI YOGINI C Department of Bio Medical Sciences, School of Health Sciences, The Apollo University, Chittoor, Andhra Pradesh, India. https://orcid.org/0009-0002-1416-9766
  • GNANESWARI K Department of Applied Microbiology and Biochemistry, Sri Padmavati Mahila Vishvavidyalayam, Women’s University, Tirupati, Andhra Pradesh, India.
  • CH KUMARI CHITTURI M Department of Applied Microbiology and Biochemistry, Sri Padmavati Mahila Vishvavidyalayam, Women’s University, Tirupati, Andhra Pradesh, India https://orcid.org/0000-0002-4427-4906

DOI:

https://doi.org/10.22159/ajpcr.2025v18i3.53290

Keywords:

Adipocytes, Obesity, cell lines, toxicity, staining

Abstract

Objectives: The objectives of the study are to investigate the effects of ethanolic extract of Undaria pinnatifida (UPEA) and methanolic extract of Moringa oleifera (MOM), alone and in combination, on the differentiation and viability of 3T3-L1 pre-adipocytes.

Methods: 3T3-L1 pre-adipocytes were treated with varying concentrations of UPEA, MOM, and their 1:1 combination. The impact on pre-adipocyte differentiation was assessed by measuring lipid accumulation. Cell viability was determined using a standard viability assay to evaluate cytotoxicity across a range of concentrations.

Results: UPEA and MOM, individually and in combination, reduced lipid accumulation in 3T3-L1 cells in a dose-dependent manner, thereby inhibiting differentiation into adipocytes. The combination treatment (1:1 ratio) demonstrated similar efficacy in reducing differentiation. Viability assays revealed minimal cytotoxic effects, with cell viability ranging from 89% to 99% across all tested concentrations.

Conclusion: UPEA, MOM, and their combination exhibit potent anti-adipogenic effects while maintaining low cytotoxicity in 3T3-L1 pre-adipocytes. These findings suggest their potential as therapeutic agents for conditions related to adipogenesis, warranting further studies on their biological activities and therapeutic mechanisms.

Downloads

Download data is not yet available.

References

Cao LM, Sun ZX, Makale EC, Du GK, Long WF, Huang HR. Antitumor activity of fucoidan: A systematic review and meta-analysis. Transl Cancer Res. 2021;10(12):5390-405. doi: 10.21037/tcr-21-1733, PMID 35116386

Wang SK, Li Y, White WL, Lu J. Extracts from New Zealand Undaria pinnatifida containing fucoxanthin as potential functional biomaterials against cancer in vitro. J Funct Biomater. 2014;5(2):29-42. doi: 10.3390/jfb5020029, PMID 24956438

Grasa-López A, Miliar-García Á, Quevedo-Corona L, Paniagua-Castro N, Escalona-Cardoso G, Reyes-Maldonado E, et al. Undaria pinnatifida and fucoxanthin ameliorate lipogenesis and markers of both inflammation and cardiovascular dysfunction in an animal model of diet-induced obesity. Mar Drugs. 2016;14(8):148. doi: 10.3390/ md14080148, PMID 27527189

Leone A, Spada A, Battezzati A, Schiraldi A, Aristil J, Bertoli S. Cultivation, genetic, ethnopharmacology, phytochemistry and pharmacology of Moringa oleifera leaves: An overview. Int J Mol Sci. 2015;16(6):12791-835. doi: 10.3390/ijms160612791, PMID 26057747

Zuorro A, García-Martínez JB, Barajas-Solano AF. The application of catalytic processes on the production of algae-based biofuels: A review. Catalysts. 2020;11(1):22. doi: 10.3390/catal11010022

Hafting JT, Craigie JS, Stengel DB, Loureiro RR, Buschmann AH, Yarish C, et al. Prospects and challenges for industrial production of seaweed bioactives. J Phycol. 2015;51(5):821-37. doi: 10.1111/ jpy.12326, PMID 26986880

Nagappan M, Park Y. Recent research trends on the enzymatic conversion of brown seaweed biomass to bioethanol. Energy Convers Manag. 2012;58:61-70.

Heo SJ, Yoon WJ, Kim KN, Ahn GN, Kang SM, Kang DH, et al. Evaluation of anti-inflammatory effect of fucoxanthin isolated from brown algae in lipopolysaccharide-stimulated RAW 264.7 macrophages. Food Chem Toxicol. 2010;48(8-9):2045-51. doi: 10.1016/j.fct.2010.05.003, PMID 20457205

Kang SM, Cha SH, Ko JY, Kang MC, Kim D, Heo SJ, et al. Neuroprotective effects of phlorotannins isolated from a brown alga, Ecklonia cava, against H2O2-induced oxidative stress in murine hippocampal HT22 cells. Environ Toxicol Pharmacol. 2012;34(1):96-105. doi: 10.1016/j.etap.2012.03.006, PMID 22465981

Mehwish HM, Riaz Rajoka MS, Xiong Y, Zheng K, Xiao H, Anjin T, et al. Moringa oleifera-a functional food and its potential immunomodulatory effects. Food Rev Int. 2022;38(7):1533-52. doi: 10.1080/87559129.2020.1825479

Himanshi PS. Anti-inflammatory activity of Codium elongatum on Carrageenan-induced paw edema in Wistar male rats. Res J Pharm Technol. 2024;17(1):197-0:197-200. doi: 10.52711/0974- 360X.2024.00031

Ashoka GB, Shivanna MB, Kuvempu University. Metabolite Proling, in-vitro and Insilco Assessment of Antibacterial and Anticancer Activities of Alternaria alternata Endophytic in Jatropha heynei; 2022. Available from: https://www.researchsquare.com/article/rs-2012393/v1.pdf

Thomaz FM, De Jesus Simão J, Da Silva VS, Machado MM, Oyama LM, Ribeiro EB, et al. Ginkgo biloba extract stimulates adipogenesis in 3T3-L1 preadipocytes. Pharmaceuticals (Basel, Switzerland). 2022;15(10):1294. doi: 10.3390/ph15101294, PMID 36297406

Etman SM, Abdallah OY, Elnaggar YS. Novel fucoidan based bioactive targeted nanoparticles from Undaria pinnatifida for treatment of pancreatic cancer. Int J Biol Macromol. 2020, 2019;145:390-401. doi: 10.1016/j.ijbiomac.2019.12.177, PMID 31881303

Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63. doi: 10.1016/0022-1759(83)90303-4, PMID 6606682

Lin Y, Qi X, Liu H, Xue K, Xu S, Tian Z. The anti-cancer effects of fucoidan: A review of both in vivo and in vitro investigations. Cancer Cell Int. 2020 May 7;20:154. doi: 10.1186/s12935-020-01233-8, PMID 32410882

Heo SJ, Ko SC, Cha SH, Lee SH, Kang DH, Park HS, et al. Effect of fucoxanthin isolated from Undaria pinnatifida on adipogenesis in vitro and in vivo. Fisheries Sci. 2009;75(2):435-43. doi: 10.3389/ fphar.2022.929442

Pareek A, Pant M, Gupta MM, Kashania P, Ratan Y, Jain V, et al. Moringa oleifera: An updated comprehensive review of its pharmacological activities, ethnomedicinal, phytopharmaceutical formulation, clinical, phytochemical, and toxicological aspects. Int J Mol Sci. 2023;24(3):2098. doi: 10.3390/ijms24032098, PMID 36768420

Muhaimin M, Chaerunisaa AY, Rostinawati T, Amalia E, Hazrina A, Nurhasanah S. A reviewon nanoparticles of Moringa oleifera extract: Preparation, characterization, and activity. Int J Appl Pharm. 2023;15(4):43-51. doi: 10.22159/ijap.2023v15i4.47709

Bhange A, Pethe A, Hadke A. Design and development of phytosomal soft nanoparticles for liver targeting. Int J Appl Pharm. 2023;15(1):280-9. doi: 10.22159/ijap.2023v15i1.46303

Rajeswari S, Vidya R, Amudha P. GCMS analysis on Andrographis paniculata seed extract and its anticancer activity. Int J Appl Pharm. 2022;14:84-8.

Published

07-03-2025

How to Cite

SAI KALYANI YOGINI C, et al. “The THERAPEUTIC POTENTIAL: UNDARIA PINNATIFIDA AND MORINGA OLEIFERA EXTRACTS AS MODULATORS OF ADIPOGENESIS IN 3T3-L1 ADIPOCYTES”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 3, Mar. 2025, pp. 93-98, doi:10.22159/ajpcr.2025v18i3.53290.

Issue

Section

Original Article(s)